Myriad Genetics (MYGN) halted with news pending
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Myriad Genetics (NASDAQ: MYGN) halted with news pending.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stocks with increasing put volume on January 20
- Deutsche Bank Starts Myriad Genetics (MYGN) at Sell
- Avino Silver & Gold Mines (ASM) Halted, News Pending
Create E-mail Alert Related CategoriesTrading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!